Literature DB >> 1630975

Recent advances in cardiology.

C F Shakespeare1, D J Coltart.   

Abstract

Mesh：

Year:  1992        PMID： 1630975      PMCID： PMC2399408          DOI： 10.1136/pgmj.68.799.327

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  65 in total

Review 1.  Gene transfer into vascular cells.

Authors:  E G Nabel; G Plautz; G J Nabel
Journal:  J Am Coll Cardiol       Date:  1991-05       Impact factor: 24.094

Review 2.  Laser balloon angioplasty: potential for reduction of the thrombogenicity of the injured arterial wall and for local application of bioprotective materials.

Authors:  J R Spears; S K Kundu; L P McMath
Journal:  J Am Coll Cardiol       Date:  1991-05       Impact factor: 24.094

3.  Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current.

Authors:  W M Jackman; X Z Wang; K J Friday; C A Roman; K P Moulton; K J Beckman; J H McClelland; N Twidale; H A Hazlitt; M I Prior
Journal:  N Engl J Med       Date:  1991-06-06       Impact factor: 91.245

4.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors:  J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

5.  Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction.

Authors:  S D Bleich; T C Nichols; R R Schumacher; D H Cooke; D A Tate; S L Teichman
Journal:  Am J Cardiol       Date:  1990-12-15       Impact factor: 2.778

6.  A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators.

Authors:  J Hsia; W P Hamilton; N Kleiman; R Roberts; B R Chaitman; A M Ross
Journal:  N Engl J Med       Date:  1990-11-22       Impact factor: 91.245

7.  Changing use of coronary angioplasty and coronary bypass surgery in the treatment of chronic coronary artery disease.

Authors:  W S Weintraub; E L Jones; S B King; J Craver; J S Douglas; R Guyton; H Liberman; D Morris
Journal:  Am J Cardiol       Date:  1990-01-15       Impact factor: 2.778

8.  Reasons for the lack of benefit of immediate angioplasty during recombinant tissue plasminogen activator therapy for acute myocardial infarction: a regional wall motion analysis. European Cooperative Study Group.

Authors:  A E Arnold; P W Serruys; W Rutsch; M L Simoons; D P de Bono; J G Tijssen; J Lubsen; M Verstraete
Journal:  J Am Coll Cardiol       Date:  1991-01       Impact factor: 24.094

9.  Percutaneous excimer laser coronary angioplasty of lesions not ideal for balloon angioplasty.

Authors:  S L Cook; N L Eigler; A Shefer; T Goldenberg; J S Forrester; F Litvack
Journal:  Circulation       Date:  1991-08       Impact factor: 29.690

10.  Suppression of the vascular response to injury: the role of angiotensin-converting enzyme inhibitors.

Authors:  J S Powell; R K Muller; H R Baumgartner
Journal:  J Am Coll Cardiol       Date:  1991-05       Impact factor: 24.094
View more
  1 in total

Review 1.  Recent advances in cardiology.

Authors:  C S Lawson; D J Coltart
Journal:  Postgrad Med J       Date:  1994-04       Impact factor: 2.401
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.